Amgen (AMGN) Stock Dips While Market Gains: Key Facts

Amgen (AMGN) closed at $407.27 in the latest trading session, marking a -3.38% move from the prior day.

Yahoo S&P Oct 1, 2026 11:50 PM

Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing

In the most recent trading session, Amgen (AMGN) closed at $385.65, indicating a +1.55% shift from the previous trading day.

Yahoo S&P Sep 19, 2026 12:50 AM

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Yahoo S&P Sep 14, 2026 4:00 PM

Amgen (AMGN) Fell 5% on a Drug That Isn’t Even Its Own. Here’s the Lp(a) Bet Now in Question.

Amgen Inc. (NASDAQ:AMGN) shed roughly $12 billion in market value after hours on September 4, 2026. The stock declined by about 5% to $415. The reason, as strange as it sounds, is …

Yahoo Finance Sep 13, 2026 5:29 PM

Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure

During the September 8 episode of Mad Money, Jim Cramer said Amgen Inc. (NASDAQ:AMGN) may have limited downside after the stock suffered its steepest one-day decline in more than t…

Yahoo Finance Sep 12, 2026 1:48 PM

Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

One company is generating billions in revenue and raising its dividend. The other is burning cash in pursuit of a scientific breakthrough that could change how diseases are treated…

Yahoo Finance Sep 11, 2026 6:29 PM

Amgen (AMGN) Dips More Than Broader Market: What You Should Know

The latest trading day saw Amgen (AMGN) settling at $382.47, representing a -2.25% change from its previous close.

Yahoo S&P Sep 11, 2026 12:50 AM

Why is Amgen stock sliding today?

Investing Stocks Sep 10, 2026 9:49 PM

Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?

Amgen trades at a fraction of Moderna's valuation, but one company is burning cash while the other generates billions, a critical divide for income-focused investors.

Yahoo Finance Sep 10, 2026 7:21 PM

HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review

Investing Stocks Sep 10, 2026 11:43 AM

Amgen and AstraZeneca report positive lung cancer trial results

Investing Stocks Sep 9, 2026 7:57 AM

Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%

Novartis just handed the entire Lp(a) drug class a failing grade, and Amgen is taking the worst of the punishment despite releasing promising trial results of its own on the very s…

Yahoo Finance Sep 8, 2026 8:08 PM

Qualcomm, Amgen, Novartis, Corning, Boeing, and More Stocks That Explain Today’s Market

Amgen falls following Swiss drugmaker Novartis’ disappointing trial data. Novartis trades sharply lower.

Yahoo S&P Sep 8, 2026 5:11 PM

Amgen Shares Fall as Investors Assess Novartis Lp(a) Trial Result and BMO Downgrade

Amgen (NASDAQ:AMGN) shares fell 4. 7% to $416.

Yahoo Finance Sep 8, 2026 1:52 PM

Why is Amgen stock sliding today?

Investing Stocks Sep 8, 2026 12:38 PM

Amgen is at 52-week highs; is there more upside

Investing Stocks Sep 3, 2026 5:07 PM

How Is Amgen’s Stock Performance Compared to Other General Drug Manufacturers

AMGN has outperformed the broader market over the past year, while analysts remain moderately bullish on its future prospects.

Yahoo Finance Aug 31, 2026 2:33 PM

AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial

Investing Stocks Aug 27, 2026 11:36 AM

2 Reasons to Like AMGN (and 1 Not So Much)

Amgen has had an impressive run over the past six months as its shares have beaten the S&P 500 by 5.7%. The stock now trades at $441.95, marking a 16.5% gain. This was partly due t…

Yahoo S&P Aug 26, 2026 3:27 PM

Beat the Market Like Zacks: Amgen, FirstCash, Delek in Focus

AMGN, FCFS and DK delivered strong gains, highlighting Zacks research successes across several model portfolios.

Yahoo S&P Aug 24, 2026 3:21 PM